Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dermatological Medicine
Volume 2017, Article ID 3194738, 5 pages
https://doi.org/10.1155/2017/3194738
Case Report

A Severe Case of Lymphomatoid Papulosis Type E Successfully Treated with Interferon-Alfa 2a

1Dermatology and Venereology Department, Akdeniz University Faculty of Medicine, Antalya, Turkey
2Pathology Department, Akdeniz University Faculty of Medicine, Antalya, Turkey
3Dermatology and Venereology Department, Ankara University Faculty of Medicine, Ankara, Turkey
4Dermatology and Venereology Department, Pamukkale University Faculty of Medicine, Denizli, Turkey

Correspondence should be addressed to Soner Uzun; moc.liamtoh@nuzunos

Received 14 January 2017; Revised 28 March 2017; Accepted 13 April 2017; Published 30 April 2017

Academic Editor: Henry Wong

Copyright © 2017 Aslı Bilgiç Temel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Willemze, E. S. Jaffe, G. Burg et al., “WHO-EORTC classification for cutaneous lymphomas,” Blood, vol. 105, no. 10, pp. 3768–3785, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Kempf, “CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators,” Journal of Cutaneous Pathology, vol. 33, 1, pp. 58–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Kempf, D. V. Kazakov, L. Scharer et al., “Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas,” The American Journal of Surgical Pathology, vol. 37, pp. 1–13, 2013. View at Google Scholar
  4. M. W. Bekkenk, F. A. Geelen, P. C. van Voorst Vader et al., “Primary and secondary cutaneous CD30(+) lymphoproliterative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment,” Blood, vol. 95, no. 12, pp. 3653–3661, 2000. View at Google Scholar · View at Scopus
  5. M. E. Kadin, “lymphomatoid papulosis and associated lymphomas: how are they related?” Archives of Dermatology, vol. 129, no. 3, pp. 351–353, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. M.-F. Demierre, L. J. Goldberg, M. E. Kadin, and H. K. Koh, “Is it lymphoma or lymphomatoid papulosis?” Journal of the American Academy of Dermatology, vol. 36, no. 5 I, pp. 765–772, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Nijsten, C. Curiel-Lewandrowski, and M. E. Kadin, “lymphomatoid papulosis in children: a retrospective cohort study of 35 cases,” Archives of Dermatology, vol. 140, no. 3, pp. 306–312, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. R. C. Beljaards and R. Willemze, “The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas,” British Journal of Dermatology, vol. 126, no. 6, pp. 596–602, 1992. View at Google Scholar · View at Scopus
  9. W. Kempf, K. Pfaltz, M. H. Vermeer et al., “EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma,” Blood, vol. 118, no. 15, pp. 4024–4035, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Duvic, N. A. Lemak, J. R. Redman et al., “Combined modality therapy for cutaneous T-cell lymphoma,” Journal of the American Academy of Dermatology, vol. 34, no. 6, pp. 1022–1029, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Yagi, Y. Tokura, F. Furukawa, and M. Takigawa, “Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-γ,” Journal of Investigative Dermatology, vol. 107, no. 6, pp. 827–832, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Schmuth, G. Topar, B. Illersperger, E. Kowald, P. O. Fritsch, and N. T. Sepp, “Therapeutic use of interferon-α for lymphomatoid papulosis,” Cancer, vol. 89, no. 7, pp. 1603–1610, 2000. View at Publisher · View at Google Scholar
  13. S. J. Proctor, G. H. Jackson, A. L. Lennard, and J. Marks, “Lymphomatoid papulosis: response to treatment with recombinant interferon alfa-2b,” Journal of Clinical Oncology, vol. 10, no. 1, p. 170, 1992. View at Publisher · View at Google Scholar · View at Scopus